APR Nov/Dec 2022 - 84
» ADVERTISER'S INDEX
»
Company
Associates of Cape Cod
BASF Corporation
Bioprocessing Summit Europe
Catalent Pharma Solutions
Contec Inc.
Eurofins BioPharma Product Testing
Gattefosse
IMA Life
INTERPHEX 2023
JRS Pharma
LGC Group
Mettler Toledo
MicroBiologics
MilliporeSigma
PDA Annual Meeting
PepTalk
SOTAX
TriLink Biotechnologies
TSI Incorporated
1. Publication Title
American Pharmaceutical Review
4. Issue Frequency
Bi-Monthly except for March and April
7. Complete Mailing Address of Known Office of Publication (Not printer) (Street, city, county, state, and ZIP+4)
395 Oyster Point Blvd., Suite 300; South San Francisco, CA 94080
8. Complete Mailing Address of Headquarters or General Business Office of Publisher (Not printer)
395 Oyster Point Blvd., Suite 300; South San Francisco, CA 94080
9. Full Names and Complete Mailing Addresses of Publisher, Editor, and Managing Editor (Do not leave blank)
Publisher (Name and complete mailing address)
Andy Miller, 395 Oyster Point Blvd., Suite 300; South San Francisco, CA 94080
Editor (Name and complete mailing address)
Mike Auerbach, 395 Oyster Point Blvd., Suite 300; South San Francisco, CA 94080
Managing Editor (Name and complete mailing address)
2. Publication Number
1099-8012
5. Number of Issues Published Annually
7
3. Filing Date
September 30, 2022
a.
6. Annual Subscription Price
$135.00
Contact Person
Andy Miller
Telephone
650-243-5212
b. Legitimate
Paid and/or
Requested
Distribution
(By Mail and
Outside the Mail)
Total Number of Copies (Net press run)
28031
Outside-County Paid/Requested Mail Subscriptions Stated on
PS Form 3541. Include direct written recipient, telemarketing,
(1) and Internet requests from recipient, paid subscriptions including
nominal rate subscriptions, employer requests, advertiser's proof
copies and exchange copies.)
In-County Paid/Requested Mail Subscriptions Stated on
PS Form 3541. Include direct written recipient, telemarketing,
(2) and Internet requests from recipient, paid subscriptions including
nominal rate subscriptions, employer requests, advertiser's proof
copies and exchange copies.)
Sales Through Dealers and Carriers, Street Vendors,
(3) Counter Sales, and Other Paid or Requested
Distribution Outside USPS.
(4) Requested Copies Distributed by Other Mail Classes Through
the USPS (e.g. First-Class Mail)
C. Total Paid and/or Requested Circulation
(Sum of 15b. (1), (2),(3),and (4)]
Outside County Nonrequested Copies Stated on PS Form 3541
(include Sample copies, Requests Over 3 years old, Requests
induced by a Premium, Bulk Sales and Requests including
(1)
d. NonRequested
Distribution
(By Mail and
10. (Do not leave blank If the publication is owned by a corporation, give the name and address of the corporation immediately followed by the
names and addresses of all stockholders owning or holding 1 percent or more of the total amount of stock. If not owned by a corporation, give the
names and addresses of the individual owners. If owned by a partnership or other unincorporated firm, give its name and address as well as those of
each individual owner. If the publication is published by a nonprofit organization, give its name and address.)
Full Name
Complete Mailing Address
CompareNetworks, Inc
395 Oyster Point Blvd., Suite 300; South San Francisco, CA 94080
Outside the Mail)
(2)
Association Requests, Names obtained from Business
Directories, Lists, and other sources).
In-County Nonrequested Copies Stated on PS Form 3541
(include Sample copies, Requests Over 3 years old, Requests
induced by a Premium, Bulk Sales and Requests including
Association Requests, Names obtained from Business
Directories, Lists, and other sources).
Nonrequested copies Distributed Through the USPS by Other
Classes of Mail (e.g. First-Class Mail, Nonrequestor Copies
(3) mailed in excess of 10% Limit mailed at Standard Mail or
Package Services Rates).
(4) Nonrequested copies Distributed Outside the Mail (Include
Pickup Stands, Trade show, Showrooms and Other Sources).
e. Total Nonrequested Distribution (Sum of 15d (1), (2), (3) and (4))
f. Total Distribution (Sum of 15c. and 15e.)
g. Copies not Distributed
h. Total (Sum of 15f and g)
i. Percent Paid and/or Requested Circulation
(15c divided by 15f x 100)
11 Known Bondholders, Mortgagees, and Other Security Holders Owning or
Holding 1 Percent or More of Total Amount of Bonds, Mortgages, or
Other Securities. If none, check box ------------------------------------------------------------------------------------Full
Name
4
4Q None
Complete Mailing Address
* If you are claiming electronic opies, go to line 16. If you are not claiming electronic copies, skip to line 17.
16. Electronic Copy Circulation
a. Requested and Paid Electronic Copies
b. Total Requested and Paid Print Copies (Line 15c) + Requested/Paid Electronic Copies
(Line 16a)
c. Total Requested Copy Distribution (Line 15f) + Requested/Paid Electronic Copies
(Line 16a)
d. Percent Paid and/or Requested Circulation (Both Print & Electronic Copies)
(16b divided by 16c x 100)
51.0%
4
4
229
12,873
26,296
1,736
28,032
47.9%
400
13,491
25,912
423
26,335
4
13,423
12,421
192
167
13,231
26,335
12,254
Page #
5
26,27
13
CV4
CV2
19
29
2
59
15
53
17
CV3
37
79
81
1
47
33
Statement of Ownership, Management, and Circulation
(Requester Publications Only)
13. Publication Title
American Pharmaceutical Review
15.
Extent and Nature of Circulation
Average No. Copies Each Issue
During Preceding 12 Months
No. Copies of Single Issue
Published Nearest to Filing Date
Web Address
www.acciusa.com
www.pharma.basf.com
www.BioprocessingEurope.com
biologics.catalent.com
www.contecinc.com
www.eurofins.com/BPT
www.gattefosse.com
www.ima.it
www.interphex.com
www.jrspharma.com
www.lgcstandards.com/mikromol
www.mt.com
www.Microbiologics.com/PerfectPairing
www.SigmaAldrich.com/BiologicsQC
pda.org/2023annual
CHI-PepTalk.com
www.sotax.com
www.trilinkbiotech.com
www.tsi.com/reliablesystem
The advertiser's index is for information purposes only. While every effort has been made to ensure it is accurate and complete, any errors or omissions are not the responsibility of the publisher.
14. Issue Date for Circulation Data Below
July/August 2022
12,644
13,091
4
4
4
4
2,630
16,053
28,925
55.5%
c I certify that 50% of all my distributed copies (electronic and print) are legitimate requests or paid copies.
17 Publication of Statement of Ownership for a Requester Publication is required and will be printed in the September/October 2022 issue of this publication.
18. Signature and Title of Editor, Publisher, Business Manager, or Owner
12. Tax Status (For completion by nonprofit organizations authorized to maiI at nonprofit rates) (Check one)
The purpose, function, and nonprofit status of this organization and the exempt status for federal income tax purposes:
Q Has Not Changed During Preceding 12 Months
c Has Changed During Preceding 12 Months (Publisher must submit explanation of change with this statement)
PS Form 3526-R, July 2014 PSN: 7530-09-000-8855
Owner
I certify that all information furnished on this form is true and complete. I understand that anyone who furnishes false or misleading information on this form
or who omits material or information requested on the form may be subject to criminal sanctions (including fines and imprisonment) and/or civil sanctions
(including civil penalties).
PS Form 3526-R, July 2014
2,591
15,012
28,503
52.7%
Date
September 30, 2022
84 |
| November/December 2022
http://www.acciusa.com
http://www.pharma.basf.com
http://www.BioprocessingEurope.com
http://biologics.catalent.com
http://Cover2
http://www.contecinc.com
http://www.eurofins.com/BPT
http://www.gattefosse.com
http://www.ima.it
http://www.interphex.com
http://www.jrspharma.com
http://www.lgcstandards.com/mikromol
http://www.mt.com
http://Cover3
http://www.Microbiologics.com/PerfectPairing
http://www.SigmaAldrich.com/BiologicsQC
http://www.pda.org/2023annual
http://www.CHI-PepTalk.com
http://www.sotax.com
http://www.trilinkbiotech.com
http://www.tsi.com/reliablesystem
APR Nov/Dec 2022
Table of Contents for the Digital Edition of APR Nov/Dec 2022
APR Nov/Dec 2022 - Cover1
APR Nov/Dec 2022 - Cover2
APR Nov/Dec 2022 - 1
APR Nov/Dec 2022 - 2
APR Nov/Dec 2022 - 3
APR Nov/Dec 2022 - 4
APR Nov/Dec 2022 - 5
APR Nov/Dec 2022 - 6
APR Nov/Dec 2022 - 7
APR Nov/Dec 2022 - 8
APR Nov/Dec 2022 - 9
APR Nov/Dec 2022 - 10
APR Nov/Dec 2022 - 11
APR Nov/Dec 2022 - 12
APR Nov/Dec 2022 - 13
APR Nov/Dec 2022 - 14
APR Nov/Dec 2022 - 15
APR Nov/Dec 2022 - 16
APR Nov/Dec 2022 - 17
APR Nov/Dec 2022 - 18
APR Nov/Dec 2022 - 19
APR Nov/Dec 2022 - 20
APR Nov/Dec 2022 - 21
APR Nov/Dec 2022 - 22
APR Nov/Dec 2022 - 23
APR Nov/Dec 2022 - 24
APR Nov/Dec 2022 - 25
APR Nov/Dec 2022 - 26
APR Nov/Dec 2022 - 27
APR Nov/Dec 2022 - 28
APR Nov/Dec 2022 - 29
APR Nov/Dec 2022 - 30
APR Nov/Dec 2022 - 31
APR Nov/Dec 2022 - 32
APR Nov/Dec 2022 - 33
APR Nov/Dec 2022 - 34
APR Nov/Dec 2022 - 35
APR Nov/Dec 2022 - 36
APR Nov/Dec 2022 - 37
APR Nov/Dec 2022 - 38
APR Nov/Dec 2022 - 39
APR Nov/Dec 2022 - 40
APR Nov/Dec 2022 - 41
APR Nov/Dec 2022 - 42
APR Nov/Dec 2022 - 43
APR Nov/Dec 2022 - 44
APR Nov/Dec 2022 - 45
APR Nov/Dec 2022 - 46
APR Nov/Dec 2022 - 47
APR Nov/Dec 2022 - 48
APR Nov/Dec 2022 - 49
APR Nov/Dec 2022 - 50
APR Nov/Dec 2022 - 51
APR Nov/Dec 2022 - 52
APR Nov/Dec 2022 - 53
APR Nov/Dec 2022 - 54
APR Nov/Dec 2022 - 55
APR Nov/Dec 2022 - 56
APR Nov/Dec 2022 - 57
APR Nov/Dec 2022 - 58
APR Nov/Dec 2022 - 59
APR Nov/Dec 2022 - 60
APR Nov/Dec 2022 - 61
APR Nov/Dec 2022 - 62
APR Nov/Dec 2022 - 63
APR Nov/Dec 2022 - 64
APR Nov/Dec 2022 - 65
APR Nov/Dec 2022 - 66
APR Nov/Dec 2022 - 67
APR Nov/Dec 2022 - 68
APR Nov/Dec 2022 - 69
APR Nov/Dec 2022 - 70
APR Nov/Dec 2022 - 71
APR Nov/Dec 2022 - 72
APR Nov/Dec 2022 - 73
APR Nov/Dec 2022 - 74
APR Nov/Dec 2022 - 75
APR Nov/Dec 2022 - 76
APR Nov/Dec 2022 - 77
APR Nov/Dec 2022 - 78
APR Nov/Dec 2022 - 79
APR Nov/Dec 2022 - 80
APR Nov/Dec 2022 - 81
APR Nov/Dec 2022 - 82
APR Nov/Dec 2022 - 83
APR Nov/Dec 2022 - 84
APR Nov/Dec 2022 - Cover3
APR Nov/Dec 2022 - Cover4
https://www.nxtbookmedia.com